Cash Flow Towa Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
26,330.00
24,459.00
4,605.00
22,246.00
18,728.00
20,709.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-10,530.00
-26,944.00
-16,829.00
-3,363.00
-13,311.00
595.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23,401.00
8,212.00
2,544.00
22,129.00
12,008.00
19,164.00
Cash Flow from Investing Activities
-31,287.00
-40,394.00
-30,284.00
-59,729.00
-9,100.00
-39,541.00
Cash Flow from Financing Activities
21,567.00
35,407.00
17,481.00
46,540.00
184.00
11,748.00
Net Cash Inflow / Outflow
15,597.00
5,392.00
-8,574.00
9,915.00
3,853.00
-7,940.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,916.00
2,167.00
1,685.00
975.00
761.00
689.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Towa Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
26330
19435
6,895.00
35.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-10530
6758
-17,288.00
-255.82%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23401
29780
-6,379.00
-21.42%
Cash Flow from Investing Activities
-31287
-19650
-11,637.00
-59.22%
Cash Flow from Financing Activities
21567
-5369
26,936.00
501.69%
Net Cash Inflow / Outflow
15597
4761
10,836.00
227.60%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1916
0
1,916.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 184.96% vs 222.80% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
23,401.00
8,212.00
184.96%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
